At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
Transcarotid Revascularization (TCAR)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
In Brief
An observational study evaluating Transcarotid Revascularization (TCAR) for Carotid Artery Diseases and 4 related conditions. Completed, enrolled 55 participants across 6 sites in 2 countries.
Detailed Summary
The goal of this evaluation is to document the incidence of post procedure DW-MRI lesions (relative to baseline) in patients treated with the transcarotid artery revascularization (TCAR) procedure.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCarotid Artery Diseases, Carotid Atherosclerosis, Carotid Stenosis, Carotid Artery Plaque, Carotid Disease
CountriesSpain, United States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJun 2019
Enrollment StartJun 2019
Primary CompletionJan 2022
TodayJul 2026
First PostedJun 11, 2019
Enrollment StartJun 27, 2019
Primary CompletionJan 19, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.1 years ago
Interventions
Transcarotid Revascularization (TCAR)procedure
Carotid revascularization treated with the FDA-cleared ENROUTE Transcarotid NPS in conjunction with the FDA-approved ENROUTE Transcarotid Stent